9/23, 3:37 PM (Source: TeleTrader)
more TeleTrader news

Fujifilm anti-coronavirus therapy shows promising results

Fujifilm announced on Wednesday that its COVID-19 antiviral therapy showed a statistically significant effect on the recovery time on patients infected with the virus without severe side effects.

The study was performed by the Fujifilm Toyama Chemical, the company's branch based in Japan, and included 156 participants. Participants receiving the drug recovered on average in 11.9 days while those who received the placebo recovered in 14.7 days.

Based on the positive data from the study the company plans to apply for drug approval this October and the expected approval could be granted within a month after the data inspection.

Breaking the News / AM